Profund Advisors LLC Fibrogen Inc Transaction History

Profund Advisors LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$2.49 - $20.59 $49,521 - $409,493	19,888 Added 42.89%	66,254 $178,000
Q1 2023 May 11, 2023	BUY	$15.95 - $25.18 $739,537 - $1.17 Million	46,366 New	46,366 $865,000
Q3 2021 Nov 12, 2021	SELL	$10.18 - $26.64 $172,998 - $452,720	-16,994 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$18.57 - $35.68 $6,202 - $11,917	-334 Reduced 1.93%	16,994 $453,000
Q1 2021 May 14, 2021	SELL	$31.0 - $55.72 $47,430 - $85,251	-1,530 Reduced 8.11%	17,328 $601,000
Q4 2020 Feb 09, 2021	BUY	$37.09 - $48.97 $70,545 - $93,140	1,902 Added 11.22%	18,858 $699,000
Q3 2020 Nov 13, 2020	SELL	$40.47 - $45.5 $88,831 - $99,872	-2,195 Reduced 11.46%	16,956 $697,000
Q2 2020 Aug 03, 2020	BUY	$32.57 - $42.83 $99,761 - $131,188	3,063 Added 19.04%	19,151 $776,000
Q1 2020 May 15, 2020	SELL	$23.3 - $45.96 $155,737 - $307,196	-6,684 Reduced 29.35%	16,088 $559,000
Q4 2019 Feb 18, 2020	BUY	$34.58 - $48.06 $101,111 - $140,527	2,924 Added 14.73%	22,772 $977,000
Q3 2019 Nov 12, 2019	SELL	$36.98 - $48.45 $23,519 - $30,814	-636 Reduced 3.1%	19,848 $734,000
Q2 2019 Aug 13, 2019	SELL	$35.13 - $55.53 $62,426 - $98,676	-1,777 Reduced 7.98%	20,484 $925,000
Q1 2019 May 15, 2019	BUY	$42.83 - $59.91 $2,227 - $3,115	52 Added 0.23%	22,261 $1.21 Million
Q4 2018 Feb 14, 2019	SELL	$37.97 - $60.16 $205,911 - $326,247	-5,423 Reduced 19.63%	22,209 $1.03 Million
Q3 2018 Nov 13, 2018	BUY	$56.3 - $67.25 $1.56 Million - $1.86 Million	27,632 New	27,632 $1.68 Million

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Profund Advisors LLC with notifications on news.